| Literature DB >> 34188198 |
Jessica K Hlay1, Graham Albert1, Carlota Batres2, George Richardson3, Caitlyn Placek4, Steven Arnocky5, Debra Lieberman6, Carolyn R Hodges-Simeon7.
Abstract
The behavioral immune system posits that disgust functions to protect animals from pathogen exposure. Therefore, cues of pathogen risk should be a primary driver influencing variation in disgust. Yet, to our knowledge, neither the relationship between current pathogen risk and disgust, nor the correlation between objective and perceived pathogen risk have been addressed using ecologically valid measures in a global sample. The current article reports two studies addressing these gaps. In Study 1, we include a global sample (n = 361) and tested the influence of both perceived pathogen exposure and an objective measure of pathogen risk-local communicable infectious disease mortality rates-on individual differences in pathogen and sexual disgust sensitivities. In Study 2, we first replicate Study 1's analyses in another large sample (n = 821), targeting four countries (US, Italy, Brazil, and India); we then replaced objective and perceived pathogen risk with variables specific to the SARS-CoV-2 pandemic. In Study 1, both local infection mortality rates and perceived infection exposure predicted unique variance in pathogen and sexual disgust. In Study 2, we found that perceived infection exposure positively predicted sexual disgust, as predicted. When substituting perceived and objective SARS-CoV-2 risk in our models, perceived risk of contracting SARS-CoV-2 positively predicted pathogen and sexual disgust, and state case rates negatively predicted pathogen disgust. Further, in both studies, objective measures of risk (i.e., local infection mortality and SARS-CoV-2 rates) positively correlated with subjective measures of risk (i.e., perceived infection exposure and perceived SARS-CoV-2 risk). Ultimately, these results provide two pieces of foundational evidence for the behavioral immune system: 1) perceptions of pathogen risk accurately assay local, objective mortality risk across countries, and 2) both perceived and objective pathogen risk explain variance in disgust levels.Entities:
Year: 2021 PMID: 34188198 PMCID: PMC8241835 DOI: 10.1038/s41598-021-91712-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Descriptive statistics of perceived infection exposure variable.
| Range | Mean | St. Dev | Cronbach’s α | |
|---|---|---|---|---|
| Study 1 | 0.00–100.00 | 27.53 | 19.59 | .83 |
| Study 2 | 0.00–100.00 | 30.79 | 27.59 | .94 |
Figure 1Study 1: relationship between perceived infection exposure, objective infection mortality rates, and disgust sensitivity.
Figure 2Study 1: sex differences. Note. Bars are standard errors. Perc Inf = perceived infection exposure. *p < .05.
Figure 3Study 2: relationship between perceived infection exposure and disgust sensitivity.
Figure 4Study 2: relationship between perceived SARS-CoV-2 risk, objective SARS-CoV-2 rates, and disgust sensitivity.
Figure 5Study 2: sex differences. Note. Bars are standard errors. Perc Inf = perceived infection exposure; Perc Risk = perceived risk of catching SARS-CoV-2. *p < .05.
Figure 6Country means of variables. Note. Perc Inf = perceived infection exposure; Perc Risk = perceived risk of catching SARS-CoV-2. *p < .05.
Figure 7(a) Correlation of state infection mortality rate and perceived infection exposure. (b) Correlation of SARS-CoV-2 case rate and perceived SARS-CoV-2 risk*.
Summary of infection variable correlations.
| State Infection Mortality Rates | |
|---|---|
| Perceived Infection | .40** |
| Perceived Infection | .33*** |
| State SARS-CoV-2 Rates | |
| Perceived SARS-CoV-2 risk | .14** |
**p < .01; ***p < .001.
Summary of results: standardized beta values from models presented in Tables S3, and S5.
| Pathogen disgust | Sexual disgust | |
|---|---|---|
| Perceived Infection | .21** | .32*** |
| Mortality Rates | .35* | .03 |
| Perceived Infection | .23 | .38*** |
| Mortality Rates | .30 | .25 |
| Perceived SARS-CoV-2 risk | .14*** | .14** |
| SARS-CoV-2 rates | -.10*** | -.06 |
*p < .05; **p < .01; ***p < .001.